Two trials report new therapy options for metastatic colorectal cancer, suggesting personalized treatment approaches.
This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, new research presented at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium detailed trials that could help to further personalize first‐line therapy options for patients with metastatic colorectal cancer. In addition, GLP‐1 receptor agonists could reduce the risk of developing colorectal cancer, and the US Health Resources and Services Administration recommends offering self‐collection for cervical cancer screening.
No takes yet. Share an insight, caveat, or question.
Leah Lawrence (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: